🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: sci.med.pharmacy
Article #175

Re: Drug interactions of Ezetimibe

#175
From: Larry Krzewinski
Date: Fri, 19 Sep 2003 17:25
69 lines
2789 bytes
On Fri, 19 Sep 2003 18:14:00 +0100, "Chris Kernaghan"
<chris.kernaghan@nospam.bicsystems.com> wrote:

>Hi guys,
>
>Does anyone know of, or have experience of drug interactions which involve
>Ciclosporin and Ezetimibe.
>
>I currently have a relative who seems to be having a reaction to something.
>
>He spikes a temperature and develops redness and inflammation,
>predominantely in his legs, but this can spread to other areas.
>
>He also has developed extreme photosensitivity, and intermittent nausea.
>
>He has a past medical history of Cardiac transplant (1986)
>
>Left Hip replacement (2003)
>
>Basal Cell Carcinoma (1996)
>
>He also has altered liver and kidney function due to prolonged use of
>Ciclosporin (for this reason Statins are inappropriate.)
>
>He also suffers from oedema in his ankles.
>
>He currently is prescribed
>
>1. Frumil (25mg mane)
>
>2. Ciclosporin (175mg BD)
>
>3. Asprin (75mg mane)
>
>4. Ranidine (150mg mane)
>
>5. Ezetimibe (10mg OD (Lunchtime))
>
>6. Minocin (100mg mane)
>
>7. Allopurinal (200mg OD (Lunchtime))
>
>8. Colchicine 500mcg PRN
>
>9. Laculose 5ml BD
>
>Has anyone any experience of  any drug interactions with any of the drugs
>listed above that would possibly cause the reactions described.
>
>TIA
>
>
>Chris Kernaghan

Chris,
You can research the drug's side effects yourself here:

http://www.healthandage.com/html/res/com/ConsLookups/Drugs.html#letA

But you have to know the correct spelling of the drugs.  Many of the
ones that you listed are misspelled making it hard to answer your
question.

Larry




Reply to larrykz at charter dot net.
Technical Details
Message-ID: <8pemmv8i436b804mpe710u37ec4rasdcl5@4ax.com>
Path: arc1-ca.pugleaf.net!archiver1.google.com!news1.google.com!newsfeed.stanford.edu!cyclone.bc.net!sjc70.webusenet.com!news.webusenet.com!sn-xit-02!sn-xit-06!sn-post-01!supernews.com!corp.supernews.com!not-for-mail
References: <3f6b3967$0$33813$65c69314@mercury.nildram.net>

Show Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII-7-bit
X-Google-Thread: fcb2d,9d3fb0112b76cb9a
X-Google-Attributes: gidfcb2d,public
X-Google-Thread: 115d97,9d3fb0112b76cb9a
X-Google-Attributes: gid115d97,public
X-Google-Thread: f4552,9d3fb0112b76cb9a
X-Google-Attributes: gidf4552,public
X-Google-ArrivalTime: 2003-09-19 10:25:03 PST
Path: arc1-ca.pugleaf.net!archiver1.google.com!news1.google.com!newsfeed.stanford.edu!cyclone.bc.net!sjc70.webusenet.com!news.webusenet.com!sn-xit-02!sn-xit-06!sn-post-01!supernews.com!corp.supernews.com!not-for-mail
From: Larry Krzewinski <Feerless_Freep@madmagazine.com>
Newsgroups: sci.med.pharmacy,bit.listserv.transplant,sci.med.immunology
Subject: Re: Drug interactions of Ezetimibe
Date: Fri, 19 Sep 2003 10:25:04 -0700
Organization: Posted via Supernews, http://www.supernews.com
Message-ID: <8pemmv8i436b804mpe710u37ec4rasdcl5@4ax.com>
References: <3f6b3967$0$33813$65c69314@mercury.nildram.net>
X-Newsreader: Forte Agent 1.93/32.576 English (American)
MIME-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Complaints-To: abuse@supernews.com
Lines: 69